Clinical Scorecard: Glaucoma Trials Tracker
At a Glance
| Category | Detail |
|---|---|
| Condition | Glaucoma, including open-angle glaucoma and ocular hypertension |
| Key Mechanisms | Lowering intraocular pressure, improving retinal and optic nerve perfusion, neuroprotection, and evaluating safety and efficacy of novel therapies and devices |
| Target Population | Patients with various types of glaucoma including refractory open-angle glaucoma, primary open-angle glaucoma, ocular hypertension, and optic neuropathies |
| Care Setting | Outpatient ophthalmology clinics and specialized eye care centers conducting clinical trials |
Key Highlights
- Multiple active interventional clinical trials evaluating new pharmacologic agents, surgical devices, and gene/cell therapies for glaucoma management
- Focus on safety, efficacy, and tolerability of treatments including novel eye drops, implants, shunts, and encapsulated cell therapies
- Exploration of retinal blood flow and ocular perfusion as biomarkers and therapeutic targets in glaucoma
Guideline-Based Recommendations
Diagnosis
- Use clinical trials to evaluate novel diagnostic biomarkers such as retinal blood flow autoregulation
- Assess intraocular pressure and optic nerve function regularly in glaucoma patients
Management
- Consider minimally invasive surgical options like iStent and iDose implants for medically uncontrolled open-angle glaucoma
- Evaluate new pharmacologic agents including ROCK inhibitors, prostaglandin analogs, and epigenetic therapies
- Use combination therapies and novel drug delivery systems to optimize intraocular pressure control
Monitoring & Follow-up
- Monitor intraocular pressure and adverse events during and after treatment with new therapies
- Assess visual field changes and optic nerve health longitudinally in clinical trials
- Evaluate conjunctival hyperemia and ocular surface effects when using combination topical therapies
Risks
- Potential adverse events related to surgical implants and novel pharmacologic agents
- Need for careful safety and tolerability assessment in early-phase trials
- Risk of treatment failure in refractory glaucoma requiring alternative interventions
Patient & Prescribing Data
Adults with mild to severe open-angle glaucoma, ocular hypertension, and optic neuropathies
Emerging therapies show promise in lowering intraocular pressure and improving ocular perfusion with acceptable safety profiles; combination and sustained-release treatments are under active investigation
Clinical Best Practices
- Incorporate evidence from ongoing clinical trials to inform treatment decisions
- Tailor glaucoma management to individual patient disease severity and response to therapy
- Utilize minimally invasive surgical options when medical therapy is insufficient
- Monitor patients closely for efficacy and adverse effects during new treatment regimens
- Engage patients in clinical trials to advance glaucoma care and access novel therapies
References
- Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation
- Efficacy and Safety Assessment of T4090 Ophthalmic Solution vs Rhopressa Ophthalmic Solution
- Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
- Rocklatan Retinal Perfusion OCT Study
- Single Site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation (PENGUIN)
- Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy
- Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanoprost 0.005% to Treat Glaucoma
- Topical Insulin for Glaucoma
- Phase 2 Study of BL1107 Eye Drops vs Timolol in Adults With Primary Open-Angle Glaucoma or Ocular Hypertension
- Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for Glaucoma
- Retinal Blood Flow and Autoregulation
- Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open-Angle Glaucoma
- Study of NT-501 Encapsulated Cell Therapy for Glaucoma Neuroprotection and Vision Restoration
- Phase 2/3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- Pilocarpine Use After Kahook Goniotomy
- A Study of PER-001 in Participants With Open-Angle Glaucoma
- Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.